LONGBOARD PHARMACEUTICALS IN
COM · Common Stock · CUSIP 54300N103
21
institutional holders
-1 vs Q1 2022
7.5m
shares reported held*
$23.3mreported value*
2 new
5 added
7 reduced
3 sold out
net sold ≈ $231.9k (-75.0k shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $3.09.
Trends to Q2 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q1 2021 | 23 |
| Q2 2021 | 18 |
| Q3 2021 | 21 |
| Q4 2021 | 22 |
| Q1 2022 | 22 |
| Q2 2022 | 21 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q2 2021 | 8 | 15 |
| Q3 2021 | 9 | 10 |
| Q4 2021 | 7 | 6 |
| Q1 2022 | 6 | 6 |
| Q2 2022 | 7 | 10 |
Biggest buyers
| CITIGROUP INC | Added | +170.2k |
| Integral Health Asset Management, LLC | Added | +9.7k |
| Tower Research Capital LLC (TRC) | Added | +2.9k |
| GEODE CAPITAL MANAGEMENT, LLC | Added | +354 |
| UBS Group AG | New | +64 |
| WELLS FARGO & COMPANY/MN | Added | +3 |
| OSAIC HOLDINGS, INC. | New | +1 |
Biggest sellers
| FMR LLC | Reduced | -157.5k |
| Alyeska Investment Group, L.P. | Reduced | -35.4k |
| BAILARD, INC. | Sold out | -21.2k |
| Veritable, L.P. | Sold out | -20.5k |
| BANK OF AMERICA CORP /DE/ | Reduced | -11.5k |
| BlackRock Inc. | Reduced | -8.9k |
| MILLENNIUM MANAGEMENT LLC | Reduced | -2.7k |
| PRICE T ROWE ASSOCIATES INC /MD/ | Reduced | -500 |
| TD Asset Management Inc | Reduced | -13 |
| MORGAN STANLEY | Sold out | -5 |
Holders, Q2 2022
| Manager | Shares | Change |
|---|---|---|
| Cormorant Asset Management, LP 0.54% of their portfolio | 2.3m $7.0m | Unchanged |
| PRICE T ROWE ASSOCIATES INC /MD/ 0.00% of their portfolio | 1.5m $4.7m | Reduced -500 |
| MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio | 1.0m $3.2m | Reduced -2.7k |
| FMR LLC 0.00% of their portfolio | 891.5k $2.8m | Reduced -157.5k |
| FARALLON CAPITAL MANAGEMENT, L.L.C. 0.01% of their portfolio | 810.5k $2.5m | Unchanged |
| CITIGROUP INC 0.00% of their portfolio | 325.0k $1.0m | Added +170.2k |
| VANGUARD GROUP INC 0.00% of their portfolio | 303.7k $938.0k | Unchanged |
| ORBIMED ADVISORS LLC 0.01% of their portfolio | 113.5k $351.0k | Unchanged |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 70.0k $216.0k | Unchanged |
| Integral Health Asset Management, LLC 0.04% of their portfolio | 57.3k $177.0k | Added +9.7k |
| TD Asset Management Inc 0.00% of their portfolio | 37.6k $116.0k | Reduced -13 |
| Alyeska Investment Group, L.P. 0.00% of their portfolio | 27.1k $84.0k | Reduced -35.4k |
| BlackRock Inc. 0.00% of their portfolio | 21.7k $67.0k | Reduced -8.9k |
| Laurion Capital Management LP 0.00% of their portfolio | 20.9k $65.0k | Unchanged |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 15.5k $47.0k | Added +354 |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 13.8k $43.0k | Reduced -11.5k |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 3.1k $10.0k | Added +2.9k |
| UBS Group AG 0.00% of their portfolio | 64 $0 | New |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 35 $0 | Added +3 |
| OSAIC HOLDINGS, INC. 0.00% of their portfolio | 1 $0 | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |